Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 6-7, Juin–Juillet 2012
Page(s) 663 - 666
Section Dernière Heure
DOI https://doi.org/10.1051/medsci/2012286022
Publié en ligne 16 juillet 2012
  1. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin A truncation in Hutchinson-Gilford progeria. Science 2003 ; 300 : 2055. [CrossRef] [PubMed]
  2. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003 ; 423 : 293–298. [CrossRef] [PubMed]
  3. Navarro CL, Poitelon Y, Lévy N. Lamines A et syndromes progéroïdes : une farnésylation persistante aux conséquences dramatiques. Med Sci (Paris) 2008 ; 24 : 833–837. [CrossRef] [EDP Sciences] [PubMed]
  4. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 ; 131 : 861–869. [CrossRef] [PubMed]
  5. Nissan X, Lemaitre G, Peschanski M, et al. Les cellules souches pluripotentes font peau neuve. Med Sci (Paris) 2010 ; 26 : 5–8. [CrossRef] [EDP Sciences] [PubMed]
  6. Nissan X, Lemaitre G, Peschanski M, et al. Les cellules souches redonnent de la couleur à la peau : une nouvelle source de mélanocytes pour la recherche clinique des pathologies pigmentaires. Med Sci (Paris) 2011 ; 27 : 935–938. [CrossRef] [EDP Sciences] [PubMed]
  7. Ho JC, Zhou T, Lai WH, et al. Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging 2011 ; 3 : 380–390. [PubMed]
  8. Liu GH, Barkho BZ, Ruiz S, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2011 ; 472 : 221–225. [CrossRef] [PubMed]
  9. Zhang J, Lian Q, Zhu G, et al. A human iPSC model of Hutchinson-Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011 ; 8 : 31–45. [CrossRef] [PubMed]
  10. Nissan X, Blondel S, Navarro CL, et al. Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome Is due to the expression of the neural-specific miR-9 microRNA. Cell Reports 2012 (sous presse).
  11. Hartmann H, Corre-menguy H, Boualem H, et al. Les microARN : une nouvelle classe de régulateurs de l’expression génique. Med Sci (Paris) 2004 ; 20 : 894–898. [CrossRef] [EDP Sciences] [PubMed]
  12. Osorio FG, Navarro CL, Cadinanos J, et al. Splicing-directed therapy in a new mouse model of human accelerated aging. Sci Transl Med 2011 ; 3 : 106ra–107. [CrossRef] [PubMed]
  13. Jung HJ, Coffinier C, Choe Y, et al. Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA. Proc Natl Acad Sci USA 2012 ; 109 : 423–431. [CrossRef]
  14. Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011 ; 24 : 849–864. [CrossRef]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.